Author:
Kalden J.R.,Burkhardt H.,Buß B.,Donhauser-Gruber U.,Erstling U.,Gromnica-Ihle E.,Karberg K.,Karger T.,Kneitz C.H.,Krause A.,Krüger K.,Lorenz H.-M.,Müller-Ladner U.,Rubbert-Roth A.,Steffens-Korbanka P.,Tony H.-P.,Wendler J.,Wollenhaupt J.,Burmester G.
Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Bejarano V, Conaghan PG, Quinn MA et al (2010) Benefits 8 yrs after a remission induction regime with an infliximab and methotrexate combination in early rheumatoid arthritis. Rheumatology 49:1971–1974
2. Bejarano V, Quinn M, Conaghan PG et al; Yorkshire Early Arthritis Register Consortium (2008) Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis. Arthritis Rheum 59:1467–1474
3. Goekoop-Ruiterman YP, Vries-Bouwstra JK de, Allaart CF et al (2005) Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 52:3381–3390
4. Hill J, Bird H, Johnson S (2001) Effect of patient education on adherence to drug treatment for rheumatoid arthritis: a randomised controlled trial. Ann Rheum Dis 60:869–875
5. Jacobsson LT, Turesson C, Gulfe A et al (2005) Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. J Rheumatol 32:1213–1218
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献